Brevan Howard Capital Management »

Akero Therapeutics shares owned by Brevan Howard Capital Management

Quarter-by-quarter ownership of Akero Therapeutics (AKRO) shares owned by Brevan Howard Capital Management from 13F filings

Historical chart of Brevan Howard Capital Management investment in Akero Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Akero Therapeutics held by Brevan Howard Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Akero Therapeutics by Brevan Howard Capital Management

Quarter filed Position value Share count Share price at filing
2024-12-31 $275k 9.9k 27.82
2024-09-30 $409k 14k 28.69
2024-06-30 $239k 10k 23.46

More positions owned by Brevan Howard Capital Management

Select Sector Spdr Tr Financial (XLF)
Ishares Tr Msci Emg Mkt Etf (EEM)
Ishares Bitcoin Trust Etf Shs Ben Int (IBIT)
Microsoft Corporation (MSFT)
Ishares Tr Iboxx Hi Yd Etf Call Option (HYG)
Invesco Qqq Tr Unit Ser 1 Call Option (QQQ)
Select Sector Spdr Tr Sbi Int-utils (XLU)
Vaneck Etf Trust Gold Miners Etf (GDX)
Spdr S&p 500 Etf Tr Tr Unit Put Option (SPY)
Select Sector Spdr Tr Sbi Healthcare Call Option (XLV)
Ishares Tr Russell 2000 Etf (IWM)
Alibaba Group Hldg Sponsored Ads (BABA)
Ishares Ethereum Tr SHS (ETHA)
Newmont Mining Corporation Call Option (NEM)
Select Sector Spdr Tr Technology Call Option (XLK)

View all positions for Brevan Howard Capital Management

Top funds holding Akero Therapeutics

Wellington Management Company
Rtw Investments
Henderson Group
BlackRock
General Atlantic
T. Rowe Price Associates
Vanguard Group
State Street Corporation
Alliancebernstein
Alkeon Capital Management
Geode Capital Management
Citadel Advisors
T. Rowe Price Investment Management
Redmile Group
Perceptive Advisors

View all funds holding Akero Therapeutics